CLDI

Calidi Biotherapeutics, Inc.

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Ken GriffinCitadel Advisors
$-16.4K
ExitQ3 2025
$16k
--
--